IART
IART
NASDAQ · Health Care

Integra Lifesciences Holding

$12.68
-3.41 (-21.19%)
As of Oct 2, 8:01 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.62B
Net Income
-511,533,792
Gross Margin
56.6%
Profit Margin
-31.6%
Rev Growth
+1.6%
D/E Ratio
1.78
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 56.6% 56.6% 67.3% 67.3%
Operating Margin -30.2% -27.2% 16.1% 18.5%
Profit Margin -31.6% -30.0% 14.6% 15.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.62B 1.59B 284.27M 289.60M
Gross Profit 917.03M 902.32M 191.26M 194.85M
Operating Income -489,933,619 -433,868,205 45.76M 53.46M
Net Income -511,533,792 -452,996,568 41.42M 44.34M
Gross Margin 56.6% 56.6% 67.3% 67.3%
Operating Margin -30.2% -27.2% 16.1% 18.5%
Profit Margin -31.6% -30.0% 14.6% 15.3%
Rev Growth +1.6% +1.6% +23.9% +16.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 391.81M 391.81M 104.07M 110.88M
Total Equity 220.26M 220.26M 274.89M 305.05M
D/E Ratio 1.78 1.78 0.38 0.36
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -475,098,182 -444,104,371 83.90M 77.61M
Free Cash Flow — — 47.45M 57.75M